Post Profile






Blink, and you would've missed that another agency is investigating the maker of EpiPen (MYL)

On Friday, Mylan, the maker of EpiPen, announced that it had reached a $465 million settlement with the US Department of Justice for overcharging the government for the life-saving drug. Mylan will not admit to wrongdoing. The settlement came faster than most, and the news sent Mylan's stock soaring. But there was actually more bad news that came with it. If you just read the Mylan's statement, and not the document it filed with the SEC, you missed that the SEC has opened its own investigation into the company for the exact same issue.
read more

share

Related Posts


Mylan cuts patient cost of EpiPen

Business & Finance : Business Insider: Clusterstock

(Reuters) - Mylan NV said it would reduce the patient cost of its severe allergy treatment drug EpiPen on Thursday, a day after Democratic Presidential candidate Hillary Clinton called for lower pricing of the drug. The company said...

The maker of the EpiPen is playing another dirty trick right from Martin Shkreli's book

Business & Finance : Business Insider: Money Game

Mylan, the company that sells the life-saving anti-allergy shot EpiPen, has said that it will provide discount coupons to patients to subsidize the $600 drug. Mylan also said that it would double the number of people eligible for it...

Mylan's generic version of the EpiPen is identical to the original — here’s why it can do that (MYL)

Business & Finance : Business Insider: Money Game

When Mylan Pharmaceuticals said Thursday that it would be giving a $300 "savings card" discount to patients buying a two-pack of EpiPens — a prescription with a retail price of around $600 — it didn't do much to fend off ire from po...

Mylan says it just cut the price of EpiPens in half — but here's the fine print (MYL)

Business & Finance : Business Insider: Clusterstock

Mylan Pharmaceuticals said Thursday that it would be giving a $300 "savings card" discount to patients buying a two-pack of EpiPens, which has a retail price of around $600. The pivot came amid pressure to cut the price of the drug ...

Not everyone is buying into Mylan's EpiPen price plan (MYL)

Business & Finance : Business Insider: Money Game

Mylan Pharmaceuticals said Thursday that it would be giving a $300 "savings card" discount for a two-pack of EpiPens, amid pressure to cut the price of the drug. Mylan has increased the price of EpiPen by 500% since it acquired the ...

Comments


Copyright © 2016 Regator, LLC